Author / Speaker: Bendicksen, Liam

Conducting Drug Affordability Reviews: Considerations for State PDABs

April 8, 2026

Identifying Therapeutic Alternatives for State PDAB Affordability Reviews

April 8, 2026

Determining Upper Payment Limits: Considerations for State PDABs

April 8, 2026

Challenging Patents to Promote Timely Generic Drug Entry: The Second Look Act and Other Options

March 16, 2026

Op-Ed: Increase Transparency at the FDA: We Need Sunlight to Fight the Pandemic

March 16, 2026

Op-Ed: Makena Is Just the Latest in Accelerated Approval Mayhem

March 16, 2026

The Vexing Voyage of Vasopressin

March 15, 2026

Anticipated Efficiencies, Real Costs: Medicaid Managed Care Organizations and the Pharmacy Benefit

March 15, 2026

Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards

March 15, 2026

Discovering a Transformative Cancer Drug: The Case of Ibrutinib

March 6, 2026

Tertiary Patents on Drugs Approved By the FDA

March 6, 2026

Pediatric Exclusivity Revenues for Cancer Drugs

March 6, 2026